Skip to main content

ADVERTISEMENT

Max M. Benson, MD

07/14/2019
We identified ACS patients from our institutional registry who underwent PCI and received either ticagrelor or clopidogrel and compared 1-year all-cause death rates.
We identified ACS patients from our institutional registry who underwent PCI and received either ticagrelor or clopidogrel and compared 1-year all-cause death rates.
We identified ACS patients from...
07/14/2019
Journal of Invasive Cardiology